Meet Our Team
TPP Management Team
Tony Chu
Managing Director
Overall Management, Licensing and Business Development, M&A, Capital raise.
​
With 30+ years of cross-border experience between the US/EU and China/SE Asia as executive management of cross-cultural teams to develop and execute strategies, tech transfer, production, licensing, investments, M&A etc.
Current and Previous
Experience as Principle, Founder and Board of Infuse, Consulting, Tardimed, China, Deal Flow London, TPPV, Capital Singapore, Eastar Chemical Corporation.
Michael Derby
Director of Finance
​Successful entrepreneur, operating executive and investor.
With 25+ years of experience in the biopharmaceutical and life sciences industries, Michael Derby is an expert in business development, licensing, and
executive leadership.
Current and Previous
Experience as Managing Partner at TardiMed, CEO of Castle Creek Pharma, President of CNS for Marathon, Founder and CEO of Norphan, Partner at Centerstone Capital and ESG Capital, and a leader in licensing and business
development at Merck.
Kris Le
QA Director
​With 20+ years of experience in the life sciences industry, Kris specializes in aseptic cGMP manufacturing. His expertise focuses on quality assurance, validation, and production process development.
Current and Previous
Experience as CEO and Principal at Amicus GMP Consultants, VP & Principal Consultant at DYNALABS LLC, and Director of 503B Operations/Pharmacist-in-Charge at Nephron 503B Outsourcing Facility.
Gerri Henwood
Interim Managing Director, TPP Lifesci LLC
With 30+ years of experience in the life sciences industry, Gerri Henwood has a proven track record of founding and leading biopharmaceutical companies. Her expertise is focused on executive leadership, business development, and commercial strategy.
Current and Previous
Experience as President & CEO at Baudax Bio, President & CEO at Recro Pharma, Inc., President of Malvern Consulting Group, Inc., President and CEO of Auxilium Pharmaceuticals, Inc., and founder and CEO of IBAH, Inc., a contract research organization. She began her career at Smith Kline & French, now part of GlaxoSmithKline plc.
Stewart Mc Callum, MD, FACS
Interim Medical Director, TPP Lifesci LLC
​With 25+ years of experience in the life sciences and healthcare industries, Stewart McCallum, MD, specializes in pharmaceuticals, clinical development, and translational research. His expertise is focused on providing fractional chief medical officer support to various companies.
Current and Previous
Experience as Consultant Chief Medical Officer at S McCallum and Associates, Chief Medical Officer at Baudax Bio, Senior Director at GlaxoSmithKline, and Assistant Professor of Urology at Stanford University.
Meet The Experts
TPP Board
Tony Chu
Board Member
Overall Management, Licensing and Business Development, M&A, Capital raise.
​
With 30+ years of cross-border experience between the US/EU and China/SE Asia as executive management of cross-cultural teams to develop and execute strategies, tech transfer, production, licensing, investments, M&A etc.
Current and Previous
Experience as Principle, Founder and Board of Infuse, Consulting, Tardimed, China, Deal Flow London, TPPV, Capital Singapore, Eastar Chemical Corporation.
Michael Derby
Board Member
​Successful entrepreneur, operating executive and investor.
With 25+ years of experience in the biopharmaceutical and life sciences industries, Michael Derby is an expert in business development, licensing, and
executive leadership.
Current and Previous
Experience as Managing Partner at TardiMed, CEO of Castle Creek Pharma, President of CNS for Marathon, Founder and CEO of Norphan, Partner at Centerstone Capital and ESG Capital, and a leader in licensing and business development at Merck.
Scott Rizzo
Board Member
With 20+ years of experience in the life sciences industry, specifically focusing on managing company operations
involving tech transfer, production, distribution and trade, M&A etc of branded and hard to make generic pharmaceuticals.
Current and Previous
Experience as Advisory Board of Vitrian, COO at Societal CDMO/CoreRx Inc, Board of Greater Hall of Chamber of Commerce of Georgia, and executive management at Barrier Therapeutics, Hoffmann-La Roche, PwC.
Joseph Hendrickson
Board Advisor
Previously lead Mylan‘s Global Injectable platform to achieve Mylan's vision as the best-in-class global supplier of high quality injectables. Built one of the most valuable sterile injectable portfolios in the industry by listening to our customers for product development and managing launch and sales/marketing and supply chain to meet the evolving needs of the marketplace.
Current and Previous
Experience as SteriScience Inc, Infuse consulting LLC, Mylan/Viatris, and Pfizer, Denver VA Medical Centers
Edward Wang
Board Advisor
Edward Wang is a healthcare executive with 20+ years of experience in pharmaceuticals, medical devices, and related industries. He holds degrees in biology and healthcare management from UC Irvine. He has led functions in R&D, clinical trials, quality, and supply chain at Fortune 500 companies and as a global consultant. Edward is a co-inventor on several patents, has published in JOC, and served as Director of AWMA’s Orange County Chapter.